Editas Medicine
Founded
2013
2013
Geography
United States of America based
United States of America based
Funding
$210 M
$210 M
Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
Technologies
CRISPR Startups Gene Therapy StartupsPosts Mentioning This Company
R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet